Business Context and Reporting Period
This Form 8-K was filed by Pavmed Inc. on June 27, 2018, reporting events related to Nasdaq listing compliance. The filing addresses a notice received on March 5, 2018, regarding failure to meet minimum market value and stockholders' equity thresholds, and the subsequent completion of a rights offering on June 12, 2018.
Key Financial Metrics
- Stockholders' Equity (Q1 2018): $247,836 (as of March 31, 2018).
- Net Proceeds from Rights Offering: $9.44 million (completed June 12, 2018).
- Current Stockholders' Equity: Estimated to be at least $2.5 million following the offering.
- Revenue, Profit, Cash Flow, Debt: The filing text does not provide clear values for these metrics.
Material Changes
The primary material change is the significant increase in stockholders' equity resulting from the equity subscription rights offering. Prior to this offering, the company failed to meet Nasdaq's minimum stockholders' equity requirement of $2.5 million and the minimum market value requirement of $35 million. The offering was executed specifically to restore compliance with Nasdaq Rule 5550(b).
Outlook, Risks, and Management Commentary
- Compliance Status: Management believes the company is now in compliance with the $2.5 million stockholders' equity standard.
- Delisting Risk: Nasdaq will continue to monitor ongoing compliance. If the company fails to evidence compliance in its next periodic report, it may be subject to delisting.
- Offering Details: The rights offering provided each stockholder with one right representing one share of common stock and one Series Z warrant.
Investor Verification Checklist
- Verify the final audited stockholders' equity figure in the next periodic report to confirm sustained compliance with the $2.5 million threshold.
- Confirm whether the company has also addressed the $35 million market value requirement or if it is relying solely on the equity standard.
- Review the terms of the Series Z warrants issued in the rights offering for potential dilution impacts.
- Monitor for any further correspondence from the Nasdaq Listing Qualifications Department regarding delisting proceedings.